Clinical Efficacy Trial of Ragon Institute-Supported HIV Vaccine Underway in Africa
Dec 1, 2017
“Mosaic” vaccine designed to respond to many viral strains, address challenge of genetic diversity. Sue McGreevey | Massachusetts General Hospital A phase 2b clinical trial of a novel preventive HIV vaccine regimen developed by researchers at the Ragon Institute of Massachusetts General Hospital (MGH), MIT and Harvard, Beth Israel Deaconess Medical Center (BIDMC), and partners has […]